Compare VRCA & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRCA | EXFY |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.3M | 110.9M |
| IPO Year | 2018 | 2021 |
| Metric | VRCA | EXFY |
|---|---|---|
| Price | $5.85 | $1.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $17.00 | $4.50 |
| AVG Volume (30 Days) | 29.4K | ★ 839.7K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $35,577,000.00 | ★ $142,101,000.00 |
| Revenue This Year | N/A | $0.42 |
| Revenue Next Year | $94.44 | $0.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 370.22 | 2.06 |
| 52 Week Low | $0.52 | $0.69 |
| 52 Week High | $9.82 | $2.55 |
| Indicator | VRCA | EXFY |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 76.41 |
| Support Level | $5.32 | $1.42 |
| Resistance Level | $6.48 | $1.72 |
| Average True Range (ATR) | 0.48 | 0.08 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 8.33 | 90.43 |
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app. Small and medium-sized businesses (SMBs) are the cornerstone of the global economy, making up almost all businesses and the majority of employment in Organization for Economic Co-operation and Development (OECD) member countries.